No Data
No Data
Lexicon Pharmaceuticals to Get $25 Million From Viatris in Global Sotagliflozin Licensing Deal
Express News | Viatris Inc - to Pay $25 Million Upfront for Sotagliflozin Rights
Express News | Viatris Announces Exclusive Licensing Agreement With Lexicon Pharmaceuticals for Sotagliflozin in All Markets Outside of the U.S. and Europe
Press Release: Viatris Announces Exclusive Licensing Agreement With Lexicon Pharmaceuticals for Sotagliflozin in All Markets Outside of the U.S. and Europe
Jefferies Maintains Viatris(VTRS.US) With Buy Rating, Maintains Target Price $15
Viatris Inc. (VTRS): A Strategic Shift in Healthcare Investments
No Data
No Data
Ape Power : KEN GRIFFIN COMMITTED FRAUD LIVE ON AIR! - AMC Stock Short Squeeze Update